Akriveia Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 23-12-2024
- Revenue 258.46%
(FY 2021)
- Profit 973.90%
(FY 2021)
- Ebitda 983.27%
(FY 2021)
- Net Worth 753.06%
(FY 2021)
- Total Assets 392.64%
(FY 2021)
About Akriveia Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Vasundhara Kamineni and Bhargavi Kamineni serve as directors at the Company.
- CIN/LLPIN
U85320TG2018PTC124547
- Company No.
124547
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Akriveia Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasundhara Kamineni  | Director | 17-May-2018 | Current |
| Bhargavi Kamineni | Director | 17-May-2018 | Current |
Financial Performance of Akriveia Laboratories.
Akriveia Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 258.46% increase. The company also saw a substantial improvement in profitability, with a 973.9% increase in profit. The company's net worth Soared by an impressive increase of 753.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akriveia Laboratories?
In 2021, Akriveia Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamineni Life Sciences Private LimitedActive 18 years 2 monthsVasundhara Kamineni and Bhargavi Kamineni are mutual person
Kamineni Fertility Center Private LimitedActive 14 years 5 monthsVasundhara Kamineni is a mutual person
Kamineni Health Care Private LimitedActive 17 years 1 monthVasundhara Kamineni and Bhargavi Kamineni are mutual person
- Kamineni Oncology Centre Private LimitedActive 26 years 11 months
Bhargavi Kamineni is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Akriveia Laboratories?
Akriveia Laboratories has a workforce of 62 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akriveia Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akriveia Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
